Scientific American Highlights U.S. Efforts To Develop Universal Flu Vaccine

Scientific American: A New Push for a Universal Flu Vaccine
“If all goes according to plan, the annual flu shot protects about 60 percent of vaccinated people. This year’s inoculation, of course, fell far short of such expectations, safeguarding only one in four vaccinated people who encountered the dominant H3N2 strain. This shortfall injected further momentum into the push to create a universal vaccine that protects against many flu types over time. … Yet the road ahead is littered with obstacles. … Earlier this month the National Institutes of Health announced one experimental vaccine, M-001, is headed into phase II clinical trials…” (Maron, 5/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.